UbiVac Overview

  • Founded
  • 2005
Founded
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $1.95M
Latest Deal Amount
  • Investors
  • 2

UbiVac General Information

Description

Developer of therapeutic vaccines intended to combat cancer and infectious diseases. The company's DPV-001 is a complex vaccine/combination immunotherapy which induces and/or boosts the immune response in every patient who receives it, enabling patients to fight cancer and increase immunity.

Contact Information

Website
www.ubivac.com
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 18183 South West Boones Ferry Road
  • Portland, OR 97224
  • United States
+1 (503) 000-0000

UbiVac Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

UbiVac Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Angel (individual) 26-Apr-2019 $1.95M 00.000 Completed Startup
6. Angel (individual) 24-May-2018 00000 00000 Completed Startup
5. Grant 18-Aug-2016 00000 Completed Startup
4. Grant 31-Aug-2014 00000 Completed Startup
3. Grant 01-Jan-2013 00000 Completed Startup
2. Grant 01-Jan-2009 $3.46M Completed Startup
1. Grant 01-Jan-2006 $152K Completed Startup
To view UbiVac’s complete valuation and funding history, request access »

UbiVac Executive Team (3)

Name Title Board Seat Contact Info
Bernard Fox Ph.D Co-Founder, President & Chief Executive Officer
Bernard Fox III Chief Operating Officer
Hong-Ming Hu Ph.D Co-Founder & Chief Scientific Officer
To view UbiVac’s complete executive team members history, request access »

UbiVac Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Cancer Institute Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view UbiVac’s complete investors history, request access »